Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest announcement is out from Nanalysis Scientific ( (TSE:NSCI) ).
Nanalysis Scientific Corp. reported its first quarter 2025 results, highlighting positive adjusted EBITDA and operating cash flow despite global macroeconomic challenges. The company achieved a significant improvement in gross margins for product sales due to cost-cutting measures and manufacturing efficiencies. However, overall revenue decreased by 5% compared to the previous year, primarily due to macroeconomic uncertainties in the United States affecting product sales. The company continues to focus on operational excellence and aims to improve service delivery margins to drive further growth.
The most recent analyst rating on (TSE:NSCI) stock is a Buy with a C$1.20 price target. To see the full list of analyst forecasts on Nanalysis Scientific stock, see the TSE:NSCI Stock Forecast page.
More about Nanalysis Scientific
Nanalysis Scientific Corp. is a leader in the development of portable NMR spectrometers and MRI technology, catering to industrial and research applications. The company focuses on building a fully vertically integrated scientific instrumentation business with innovative products and a growing service business.
Average Trading Volume: 47,988
Technical Sentiment Signal: Sell
Current Market Cap: C$29.44M
For detailed information about NSCI stock, go to TipRanks’ Stock Analysis page.